314 results on '"Nóbrega, Clévio"'
Search Results
2. Brain-targeted drug delivery - nanovesicles directed to specific brain cells by brain-targeting ligands
3. The polyglutamine protein ATXN2: from its molecular functions to its involvement in disease
4. Measuring healthy ageing: current and future tools
5. Reprogramming iPSCs to study age-related diseases: Models, therapeutics, and clinical trials
6. RNA Interference Applications for Machado-Joseph Disease
7. Gene Therapy Applications
8. Gene Editing
9. Gene Therapy Strategies: Gene Augmentation
10. Barriers to Gene Delivery
11. Gene Therapy Strategies: Gene Silencing
12. Gene and Cell Therapy
13. Stem Cells and Tissue Regeneration
14. Viral Vectors for Gene Therapy
15. Non-viral Vectors for Gene Therapy
16. From the disruption of RNA metabolism to the targeting of RNA‐binding proteins: The case of polyglutamine spinocerebellar ataxias.
17. Gene Therapies for Polyglutamine Diseases
18. Stem Cell-Based Therapies for Polyglutamine Diseases
19. Molecular Mechanisms and Cellular Pathways Implicated in Machado-Joseph Disease Pathogenesis
20. Molecular Biology of Human Obesity: Nonepigenetics in Comparison with Epigenetic Processes
21. From the disruption of RNA metabolism to the targeting of RNA‐binding proteins: The case of polyglutamine spinocerebellar ataxias
22. Autophagy in Spinocerebellar ataxia type 2, a dysregulated pathway, and a target for therapy
23. Restoring brain cholesterol turnover improves autophagy and has therapeutic potential in mouse models of spinocerebellar ataxia
24. Stress granules, RNA-binding proteins and polyglutamine diseases: too much aggregation?
25. Reprogramming iPSCs to study age-related diseases: Models, therapeutics, and clinical trials
26. A Handbook of Gene and Cell Therapy
27. On the role of RNA binding proteins in polyglutamine diseases: from pathogenesis to therapeutics
28. Autophagy in Spinocerebellar Ataxia Type 3: From Pathogenesis to Therapeutics
29. Epigenetics of Human Obesity: A Link Between Genetics and Nutrition
30. Genetic Contribution: Common Forms of Obesity
31. Genetics of Human Obesity
32. Unraveling the Role of Ataxin-2 in Metabolism
33. Lauroylated Histidine-Enriched S413-PV Peptide as an Efficient Gene Silencing Mediator in Cancer Cells
34. Trehalose alleviates the phenotype of Machado–Joseph disease mouse models
35. Role of Mitochondrial Dysfunction in Human Obesity
36. Editorial: Global excellence in gene and cell therapy: Europe
37. Editorial: Advanced (gene and cell) therapies for central nervous system applications
38. PolyQ Database—an integrated database on polyglutamine diseases
39. Ataxin-2 in the hypothalamus at the crossroads between metabolism and clock genes
40. Intravenous administration of brain-targeted stable nucleic acid lipid particles alleviates Machado-Joseph disease neurological phenotype
41. Stem Cell-Based Therapies for Polyglutamine Diseases
42. Molecular Mechanisms and Cellular Pathways Implicated in Machado-Joseph Disease Pathogenesis
43. Gene Therapies for Polyglutamine Diseases
44. The stress granule protein G3BP1 alleviates spinocerebellar ataxia-associated deficits
45. The stress granule protein G3BP1 reduces the levels of polyglutamine proteins and alleviates spinocerebellar ataxia associated deficits
46. Mutant Ataxin-2 Expression in Aged Animals Aggravates Neuropathological Features Associated with Spinocerebellar Ataxia Type 2
47. Neuropeptide Y stimulates autophagy in hypothalamic neurons
48. Molecular Biology of Human Obesity: Non-epigenetics in Comparison with Epigenetic Processes
49. stress granule protein G3BP1 alleviates spinocerebellar ataxia-associated deficits.
50. Autophagy is dysregulated in spinocerebellar ataxia type 2
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.